Siddappa N Byrareddy

InstitutionUniversity of Nebraska Medical Center
AddressOmaha
Nebraska
United States
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 23 Covid-19 publications, with a maximum of 3 publications in August 2020 and August 2021
    All Publications
    Bar chart showing 65 publications over 9 distinct years, with a maximum of 16 publications in 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Hanna J, Tipparaju P, Mulherkar T, Lin E, Mischley V, Kulkarni R, Bolton A, Byrareddy SN, Jain P. Risk Factors Associated with the Clinical Outcomes of COVID-19 and Its Variants in the Context of Cytokine Storm and Therapeutics/Vaccine Development Challenges. Vaccines (Basel). 2021 Aug 23; 9(8). PMID: 34452063.
      Citations:    
    2. Kannan SR, Spratt AN, Cohen AR, Naqvi SH, Chand HS, Quinn TP, Lorson CL, Byrareddy SN, Singh K. Evolutionary analysis of the Delta and Delta Plus variants of the SARS-CoV-2 viruses. J Autoimmun. 2021 11; 124:102715. PMID: 34399188.
      Citations: 14     Fields:    Translation:Humans
    3. Johnson SD, Olwenyi OA, Bhyravbhatla N, Thurman M, Pandey K, Klug EA, Johnston M, Dyavar SR, Acharya A, Podany AT, Fletcher CV, Mohan M, Singh K, Byrareddy SN. Therapeutic implications of SARS-CoV-2 dysregulation of the gut-brain-lung axis. World J Gastroenterol. 2021 Aug 07; 27(29):4763-4783. PMID: 34447225.
      Citations:    Fields:    Translation:HumansPHPublic Health
    4. Spratt AN, Kannan SR, Woods LT, Weisman GA, Quinn TP, Lorson CL, Sönnerborg A, Byrareddy SN, Singh K. Evolution, correlation, structural impact and dynamics of emerging SARS-CoV-2 variants. Comput Struct Biotechnol J. 2021; 19:3799-3809. PMID: 34188776.
      Citations: 3     
    5. Saccon E, Chen X, Mikaeloff F, Rodriguez JE, Szekely L, Vinhas BS, Krishnan S, Byrareddy SN, Frisan T, Végvári Á, Mirazimi A, Neogi U, Gupta S. Cell-type-resolved quantitative proteomics map of interferon response against SARS-CoV-2. iScience. 2021 May 21; 24(5):102420. PMID: 33898942.
      Citations: 4     
    6. Patel RH, Acharya A, Chand HS, Mohan M, Byrareddy SN. Human Immunodeficiency Virus and Severe Acute Respiratory Syndrome Coronavirus 2 Coinfection: A Systematic Review of the Literature and Challenges. AIDS Res Hum Retroviruses. 2021 04; 37(4):266-282. PMID: 33599163.
      Citations: 2     Fields:    Translation:Humans
    7. Pathania AS, Prathipati P, Abdul BA, Chava S, Katta SS, Gupta SC, Gangula PR, Pandey MK, Durden DL, Byrareddy SN, Challagundla KB. COVID-19 and Cancer Comorbidity: Therapeutic Opportunities and Challenges. Theranostics. 2021; 11(2):731-753. PMID: 33391502.
      Citations: 8     Fields:    Translation:HumansCellsPHPublic Health
    8. Pandey K, Acharya A, Mohan M, Ng CL, Reid SP, Byrareddy SN. Animal models for SARS-CoV-2 research: A comprehensive literature review. Transbound Emerg Dis. 2021 Jul; 68(4):1868-1885. PMID: 33128861.
      Citations: 16     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    9. Srinivasa Rao ASR, Krantz SG, Bonsall MB, Kurien T, Byrareddy SN, Swanson DA, Bhat R, Sudhakar K. How relevant is the basic reproductive number computed during the coronavirus disease 2019 (COVID-19) pandemic, especially during lockdowns? Infect Control Hosp Epidemiol. 2022 Jan; 43(1):125-127. PMID: 33308355.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    10. Trivedi J, Mohan M, Byrareddy SN. Drug Repurposing Approaches to Combating Viral Infections. J Clin Med. 2020 Nov 23; 9(11). PMID: 33238464.
      Citations: 3     
    11. Tiwari R, Mishra AR, Mishra AR, Mikaeloff F, Gupta S, Mirazimi A, Byrareddy SN, Neogi U, Nayak D. In silico and in vitro studies reveal complement system drives coagulation cascade in SARS-CoV-2 pathogenesis. Comput Struct Biotechnol J. 2020; 18:3734-3744. PMID: 33200027.
      Citations: 3     
    12. Rothan HA, Byrareddy SN. The potential threat of multisystem inflammatory syndrome in children during the COVID-19 pandemic. Pediatr Allergy Immunol. 2021 01; 32(1):17-22. PMID: 32897642.
      Citations: 8     Fields:    Translation:HumansPHPublic Health
    13. Husain A, Byrareddy SN. Rapamycin as a potential repurpose drug candidate for the treatment of COVID-19. Chem Biol Interact. 2020 Nov 01; 331:109282. PMID: 33031791.
      Citations: 15     Fields:    Translation:HumansCellsPHPublic Health
    14. Kannan SR, Spratt AN, Quinn TP, Heng X, Lorson CL, Sönnerborg A, Byrareddy SN, Singh K. Infectivity of SARS-CoV-2: there Is Something More than D614G? J Neuroimmune Pharmacol. 2020 12; 15(4):574-577. PMID: 32930936.
      Citations: 17     Fields:    Translation:HumansCells
    15. Patel RH, Acharya A, Mohan M, Byrareddy SN. COVID-19 and AIDS: Outcomes from the coexistence of two global pandemics and the importance of chronic antiretroviral therapy. J Med Virol. 2021 02; 93(2):641-643. PMID: 32779740.
      Citations: 5     Fields:    Translation:HumansCellsPHPublic Health
    16. Olwenyi OA, Dyavar SR, Acharya A, Podany AT, Fletcher CV, Ng CL, Reid SP, Byrareddy SN. Immuno-epidemiology and pathophysiology of coronavirus disease 2019 (COVID-19). J Mol Med (Berl). 2020 10; 98(10):1369-1383. PMID: 32808094.
      Citations: 11     Fields:    Translation:HumansCellsPHPublic Health
    17. Mishra PK, Tandon R, Byrareddy SN. Diabetes and COVID-19 risk: an miRNA perspective. Am J Physiol Heart Circ Physiol. 2020 09 01; 319(3):H604-H609. PMID: 32762561.
      Citations: 4     Fields:    Translation:HumansAnimalsPHPublic Health
    18. Singu S, Acharya A, Challagundla K, Byrareddy SN. Impact of Social Determinants of Health on the Emerging COVID-19 Pandemic in the United States. Front Public Health. 2020; 8:406. PMID: 32793544.
      Citations: 47     Translation:HumansPHPublic Health
    19. Rothan HA, Acharya A, Reid SP, Kumar M, Byrareddy SN. Molecular Aspects of COVID-19 Differential Pathogenesis. Pathogens. 2020 Jul 06; 9(7). PMID: 32640525.
      Citations: 6     
    20. Acharya A, Kevadiya BD, Gendelman HE, Byrareddy SN. SARS-CoV-2 Infection Leads to Neurological Dysfunction. J Neuroimmune Pharmacol. 2020 06; 15(2):167-173. PMID: 32447746.
      Citations: 24     Fields:    Translation:HumansCellsPHPublic Health
    21. Byrareddy SN, Mohan M. SARS-CoV2 induced respiratory distress: Can cannabinoids be added to anti-viral therapies to reduce lung inflammation? Brain Behav Immun. 2020 07; 87:120-121. PMID: 32360437.
      Citations: 14     Fields:    Translation:Humans
    22. Neogi U, Hill KJ, Ambikan AT, Heng X, Quinn TP, Byrareddy SN, Sönnerborg A, Sarafianos SG, Singh K. Feasibility of Known RNA Polymerase Inhibitors as Anti-SARS-CoV-2 Drugs. Pathogens. 2020 Apr 26; 9(5). PMID: 32357471.
      Citations: 14     
    23. Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020 05; 109:102433. PMID: 32113704.
      Citations: 1252     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    Byrareddy's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (195)
    Explore
    _
    Co-Authors (82)
    Explore
    _
    Similar People (60)
    Explore
    _